Where Global Clinical Development Leaders Connect - Bridging China, Asia and the West
We focus on quality of audience, not quantity by specifically aiming for a group of around 500 attendees. We believe that this is the right number to ensure that our audience is made up of mostly decision-makers from global pharmaceutical and biotech companies.
Initial Slate of Hot Topics Planned for 2025...
-
China’s Role in the Global Drug Development Ecosystem
-
How Integrated Clinical Development With China Can Accelerate Global Biotechs' Business Development Ambitions
-
IND vs IIT in China: How Can Global Biotechs Leverage IITs to Expedite Early Development?
- Co-Development & Investment Opportunities from China and Asia: Are They a Good Fit For Your Biotech?
- Leveraging AI to Improve Efficiency and Quality in Clinical Development
-
Quality of Clinical Trials in China: Where Are the Gaps in 2025?
- The Future of Cell Therapy: In-Vivo CAR-T Clinical Innovation in China
-
Translational Research and China's Impact on US Drug Development
- What Are the Strengths of Key APAC Regions (Singapore, Japan, Korea, Australia) for Global Drug Development?
- Leveraging AI to Improve Efficiency and Quality in Clinical Development
- East Meets EU: Strategies for Chinese Biotechs to Expand to Europe
- Impact of FDA's Plan to Phase Out Animal Testing on Global Clinical Development
- xDC Clinical Development in China
NEW FOR 2025!
Global Perspective
CHINATRIALS expands beyond clinical development to explore the full R&D spectrum from pipeline strategy to business development to offer a holistic view of biotech innovation.
Regional Perspective
We’re spotlighting China’s growing role in global drug development along with emerging regional ecosystems in Asia including Japan, Singapore, Korea, and Australia.
Platform for Collaboration
With a new track on Licensing, BD, and Investment, CHINATRIALS is your gateway to deal-making, funding, and building partnerships with China and Asia's dynamic biopharma sector.
Staying True to Our Clinical Development Focus
Clinical development remains our core, with in-depth sessions on trial strategy, design, operations, and global regulatory trends to accelerate drug development worldwide.
Two-Way Street
Distinct tracks and coverage for both global biotech companies looking to enter China and Chinese biotechs looking to go global resulting in a beautiful mix for networking.
How Will You Benefit From Attending?
Senior-Level Attendee Profile
Over 75% of attendees at ChinaTrials are director-level and above. The majority of attendees are from multinational and domestic Chinese pharmaceutical, biotech and medical device companies. Relevant government regulatory officials, university professors and investigators from China’s top hospitals also attend the event.
Endless Networking Opportunities
Over 15 hours of dedicated networking time is directly built into the program agenda to facilitate introductions between potential new business contacts in informal settings such as luncheons and cocktail receptions.
Meet All Major CROs and Clinical Development Service Providers at One Event
Meet the region's leading CROs, CDMOs and clinical partners- all in one place.
Presentation Topics Selected By and For Industry Executives
We spend hundreds of hours of market research, talking to hundreds of clinical development executives in every job function from every region. This is why ChinaTrials provides the best coverage of the hottest topics by the highest quality speakers of any China clinical event.
The Most In-Depth Clinical Development Event
In just two and half days, you will hear from and meet all the top experts in the China clinical development field and you will meet and exchange ideas with hundreds of your peers from the BioPharma and Device industries. The invaluable information you take away from attending the meeting will have an immediate impact on your daily business activities.
Business Development & Investment Track + 1:1 Meetings
Accelerate your partnerships. CHINATRIALS 17 now features a dedicated Asia BD & Investment Track and exclusive 1:1 meetings to help you connect directly with top decision-makers and forge cross-border deals.